THERAPEUTIC CLASS
Pathogenesis of Gastric Cancer
Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. GC is a heterogeneous disease and the endpoint of a long multistep process largely influenced by Helicobacter pylori infection, genetic susceptibility, and environmental factors. In a subset of GC cases, infection with the Epstein–Barr virus (EBV) may also be
involved. The development of GC is the consequence of the accumulation of multiple epi/genetic changes during the patient’s lifetime that will result in oncogenic activation and/or tumor suppressor pathways’ inactivation.
No other version available